Page 5 - Laurie Hurst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Laurie hurst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Laurie Hurst Today - Breaking & Trending Today

PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma - News Makers


PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act.
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma
®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, are using Synoma to link data and conduct analyses across their drug development portfolios. ....

United States , Kent Thoelke , Jane Quigley , Digital Health , Drug Administration , Symphony Health , Health Sciences Inc , Health Sciences , Century Cures , Executive Vice President , Chief Scientific Officer , Senior Vice President , North America , Latin America , Middle East , Laurie Hurst , ஒன்றுபட்டது மாநிலங்களில் , ஜேன் குயிக்லி , டிஜிட்டல் ஆரோக்கியம் , சிம்பொனி ஆரோக்கியம் , ஆரோக்கியம் அறிவியல் இன்க் , ஆரோக்கியம் அறிவியல் , சிஇஎன்டியுவ்ஆர்ஒய் குணப்படுத்துகிறது , நிர்வாகி துணை ப்ரெஸிடெஂட் , தலைமை அறிவியல் அதிகாரி , மூத்தவர் துணை ப்ரெஸிடெஂட் ,

PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma | Comunicados | Edición USA


13 may 2021
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act.
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma
®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, are using Synoma to link data and conduct analyses across their drug development portfolios. ....

United States , Kent Thoelke , Jane Quigley , Digital Health , Drug Administration , Pra Health Sciences , Symphony Health , Health Sciences Inc , Health Sciences , Century Cures , Executive Vice President , Chief Scientific Officer , Senior Vice President , North America , Latin America , Middle East , Laurie Hurst , ஒன்றுபட்டது மாநிலங்களில் , ஜேன் குயிக்லி , டிஜிட்டல் ஆரோக்கியம் , பிர ஆரோக்கியம் அறிவியல் , சிம்பொனி ஆரோக்கியம் , ஆரோக்கியம் அறிவியல் இன்க் , ஆரோக்கியம் அறிவியல் , சிஇஎன்டியுவ்ஆர்ஒய் குணப்படுத்துகிறது , நிர்வாகி துணை ப்ரெஸிடெஂட் ,

PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics - News Makers


PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics
PRA offers post-authorization safety solutions to keep up with the speed of COVID-19 vaccine and therapeutic pharmacovigilance requirements
RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including post-authorization safety studies (PASS) delivered by Real World Solutions. With more than 25 years of experience executing comprehensive pharmacovigilance and patient safety services in all key therapeutic areas including infectious diseases, PRA can work closely with drug developers and manufacturers in ensuring long-term safety and efficacy of COVID-19 vaccines and treatments. ....

United States , Greg Licholai , Sabine Richter , Monitoring Program , Health Science , Drug Administration , Health Platform , Health Sciences , Real World Solutions , Real World , Marketing Authorization Holders , Vice President , Patient Safety , Emerging Infectious Diseases , Senior Vice President , Chief Medical Information Officer , Mobile Health Platform , North America , Latin America , Middle East , Laurie Hurst , ஒன்றுபட்டது மாநிலங்களில் , கண்காணிப்பு ப்ரோக்ர்யாம் , ஆரோக்கியம் அறிவியல் , ஆரோக்கியம் நடைமேடை , ரியல் உலகம் தீர்வுகள் ,